ATRS

Antares Pharma, Inc. News Headlines

$2.06
*  
0.05
2.37%
Get ATRS Alerts
*Delayed - data as of Aug. 3, 2015  -  Find a broker to begin trading ATRS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ATRS Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By











Dilution Is The Solution To Pollution
10/9/2012 12:24:00 PM - Seeking Alpha






Reconsidering Zalicus And Antares In Light Of Shakeups
10/3/2012 1:35:00 AM - Seeking Alpha




Under Construction Rehash: Buy Acadia And Astex
9/20/2012 9:58:00 AM - Seeking Alpha


'BioRunUp' Call: Buy Acadia And Astex
9/19/2012 11:51:00 AM - Seeking Alpha














Near-Term Stock Catalysts For These Bio-Pharmas
3/7/2012 3:10:00 AM - Seeking Alpha


4 Biopharma Swing Trades For The Mid Term
3/5/2012 11:10:00 AM - Seeking Alpha


7 Reasons To Consider Buying Antares Pharma
3/5/2012 3:30:00 AM - Seeking Alpha


Antares: Catalysts Foretell Surge Coming
2/29/2012 4:26:00 PM - Seeking Alpha


Spectrum Pharma's Business Model Is A Winner
2/27/2012 3:58:00 PM - Seeking Alpha


Earnings Call Highlights From These 2 Bio-Pharmas
2/24/2012 3:13:00 AM - Seeking Alpha


Update: Teva And Antares's Generic Challenge To EpiPen
2/23/2012 4:40:00 PM - Seeking Alpha